Sunshine Biopharma Inc (SBFM)
0.93
+0.04
(+4.49%)
USD |
NASDAQ |
May 17, 16:00
0.92
-0.01
(-1.08%)
After-Hours: 20:00
Sunshine Biopharma Cash from Operations (TTM): -8.775M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -8.775M |
| September 30, 2023 | -8.332M |
| June 30, 2023 | -8.998M |
| March 31, 2023 | -5.794M |
| December 31, 2022 | -5.248M |
| September 30, 2022 | -3.314M |
| June 30, 2022 | -2.791M |
| March 31, 2022 | -2.836M |
| December 31, 2021 | -1.829M |
| September 30, 2021 | -1.941M |
| June 30, 2021 | -1.460M |
| March 31, 2021 | -0.9236M |
| December 31, 2020 | -0.6573M |
| September 30, 2020 | -0.3615M |
| June 30, 2020 | -0.3274M |
| March 31, 2020 | -0.2929M |
| December 31, 2019 | -0.4958M |
| September 30, 2019 | -0.484M |
| June 30, 2019 | -0.5683M |
| March 31, 2019 | -0.5783M |
| December 31, 2018 | -0.5128M |
| September 30, 2018 | -0.6062M |
| June 30, 2018 | -0.5836M |
| March 31, 2018 | -0.6039M |
| December 31, 2017 | -0.5435M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.3652M |
| June 30, 2017 | -0.28M |
| March 31, 2017 | -0.3406M |
| December 31, 2016 | -0.3142M |
| September 30, 2016 | -0.6258M |
| June 30, 2016 | -0.6654M |
| March 31, 2016 | -0.8362M |
| December 31, 2015 | -0.8676M |
| September 30, 2015 | -0.7726M |
| June 30, 2015 | -0.688M |
| March 31, 2015 | -0.5608M |
| December 31, 2014 | -0.5386M |
| September 30, 2014 | -0.3306M |
| June 30, 2014 | -0.3982M |
| March 31, 2014 | -0.3155M |
| December 31, 2013 | -0.5644M |
| September 30, 2013 | -0.6974M |
| June 30, 2013 | -0.7721M |
| March 31, 2013 | -0.698M |
| December 31, 2012 | -0.3931M |
| September 30, 2012 | -0.3381M |
| June 30, 2012 | -0.2961M |
| March 31, 2012 | -0.2877M |
| December 31, 2011 | -0.2973M |
| September 30, 2011 | -0.4239M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-8.998M
Minimum
Jun 2023
-0.2929M
Maximum
Mar 2020
-2.917M
Average
-1.829M
Median
Dec 2021
Cash from Operations (TTM) Benchmarks
| Lexaria Bioscience Corp | -5.209M |
| Acasti Pharma Inc | -13.57M |
| Aurinia Pharmaceuticals Inc | -33.46M |
| Edesa Biotech Inc | -6.340M |
| Xenon Pharmaceuticals Inc | -154.09M |